Literature Review - NEW
Following an event hosted by Stephen Hughes MEP at the European Parliament in Brussels today - February 20th, 2013 - the new EASL publication 'The Burden of Liver Disease in Europe: A review of Available Epidemiological Data' has been published by EASL.
The report which can be viewed and downloaded below reviews 260 epidemiological studies published in the last five years to survey the current state of evidence on the burden of liver disease in Europe and its causes. The report looks at the leading causes of cirrhosis and primary liver cancer in Europe: alcohol consumption, viral hepatitis B and C and metabolic syndromes related to overweight and obesity. In addition, the report also looks at the incidence and prevalence of Hepatitis A, D, and E, of Drug induced liver injuries (DILI), Haemochromatosis, Autoimmune hepatitis, Primary biliary cirrhosis (PBC) and Primary sclerosing cholangitis (PSC).
For further information please contact Margaret Walker, EASL Director of EU Public Affairs at email@example.com
Printed copies of the Literature Review will be available at The International Liver Congress™ 2013, Amsterdam, The Netherlands, April 24 - 28, 2013 at the RAI Convention Centre. This venue will be the 48th annual meeting of the European Association for the Study of the Liver. Come and collect your copy from the EU area of the EASL Booth (Hall 2), and get more information directly from Margaret.
Many ways one aim … the conquest of all liver disease
- Liver disease is estimated to affect 6% of the EU’s population
- Liver disease is reported to be the EU’s 5th most common cause of death, accounting for at least one in six deaths
- Liver cancer is the third most common cause of cancer-related mortality globally
- Hepatitis, the most common liver disease, is estimated to affect over 10 million people in Europe
- Alcohol consumption is the 3rd largest cause of early death and illness in the EU, just behind tobacco and high blood pressure. Excessive and chronic alcohol consumption leads to increased prevalence of liver cirrhosis and liver cancer.